A service of StreetInsider.com

Most Popular

AAPL 140.02
C 26.20
GOOG 408.49
BAC 27.40
RIMM 69.71

Recently Added

FTR 29.86
ARDM 0.24
SLAT 0.67
LNT 25.80
NDN 26.28

Gaining Speed

ACCP 2.20
XYNH 0.01
SAPE 6.13
CSG 45.46
CWST 2.04
5.90 -0.35 (-5.71%) VVUS

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:5.90 Change:-0.35 (-5.71%) Prev Close:6.25 Open: 6.13 Days Range:5.87 – 6.30 52 Week Range: 2.72 - 9.27 Volume:627123 P/E: N/A
EPS:-0.15

Member Comments

No member comments available for VVUS


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 07/04/09

Recent Alert on 06/08/09 at 7:53am
Weight Loss With Vivus (VVUS) Qnexa Stops Progression Toward Type 2 Diabetes in Obese Non-Diabetic Patients

VIVUS, Inc. (Nasdaq: VVUS) reported the glycemic findings from EQUATE (OB-301), a phase 3 trial evaluating Qnexa(TM) in non-diabetic, obese patients. After 28 weeks of treatment, blood sugar levels, as measured by hemoglobin A1c (HbA1c), were lower... Read More

Recent Alert on 05/11/09 at 4:06pm
Vivus (VVUS) Reports Q1 Loss of $0.10, Misses by 3c

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

SEC Filing on 07/02/09 at 4:16pm
Form 4 VIVUS INC For: Jun 30 Filed by: MARSH GUY P
SEC Filing on 06/30/09 at 4:18pm
Form 4 VIVUS INC For: Jun 26 Filed by: MARSH GUY P
SEC Filing on 06/30/09 at 4:18pm
Form 4 SHORTLIFFE LINDA M DAIRI For: Jun 26
SEC Filing on 06/30/09 at 4:17pm
Form 4 VIVUS INC For: Jun 26 Filed by: LOGAN MARK B

View AllRecent Blog Posts

Blog Posts on 05/12/09 at 4:45am
Vivus: Still Undervalued
Blog Posts on 04/05/09 at 5:58am
Orexigen's Contrave: Generic Would Be No Cheaper
Blog Posts on 04/02/09 at 4:41am
Arena, The Aftermath